Trial Profile
A study evaluating effect of food on Pharmacokinetics of Ertugliflozin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2018
Price :
$35
*
At a glance
- Drugs Ertugliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 05 Apr 2017 New trial record
- 18 Mar 2017 Results (n=42) assessing effect of food on pharmacokinetics of Ertugliflozin and its FDCs using patient data from this and other two trials, (See CTPs 283429, 283430), presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics